News Focus
News Focus
Followers 24
Posts 4136
Boards Moderated 0
Alias Born 12/18/2019

Re: biosectinvestor post# 564794

Saturday, 02/04/2023 3:46:20 PM

Saturday, February 04, 2023 3:46:20 PM

Post# of 819473
The Optune trials were APPROVED by regulators -- the highest bar for a trial. NWBO has NOT.

The JAMA Oncology manuscript only references Complete or near complete resection -- that was the requirement to meet the inclusion screener. The ECA trials allowed biopsy only patients that leave considerable tumor. There is a significant difference in expected survival from tumor between Complete resection and a biopsy.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474933/

This a significant bias that has been repeatedly pointed out by the neuro-oncologist critics of the trial.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News